Gainers & Losers
Wed May 14 2025 10:29:33- Tata Steel share price
- ₹155.303.88%
- Tech Mahindra share price
- ₹1,604.252.02%
- Mahindra And Mahindra share price
- ₹3,101.651.56%
- Infosys share price
- ₹1,592.601.50%
- Maruti Suzuki India share price
- ₹12,672.001.50%
Active Stocks
Wed May 14 2025 10:29:33- Tata Steel share price
- ₹155.303.88%
- Bharat Electronics share price
- ₹344.352.56%
- Tata Motors share price
- ₹699.00-1.26%
- Bharti Airtel share price
- ₹1,834.400.74%
- Zee Entertainment Enterpri...
- ₹123.850.57%
Business News/Market/Market Stats/Astrazeneca Pharma India share price/ Astrazeneca Pharma India Balance Sheet Annual
Astrazeneca Pharma India Balance Sheet Annual
8,040.10 -143.25 (-1.75%)Updated : 14 May 2025
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Cash | 18.87 | 2.50 | 8.82 | 3.01 |
| Cash Equivalents | 486.70 | 497.84 | 439.60 | 349.33 |
| Cashand Short Term Investments | 505.57 | 500.34 | 448.51 | 352.34 |
| Accounts Receivable- Trade Net | 155.40 | 109.31 | 87.71 | 86.64 |
| Total Receivables Net | 185.40 | 132.50 | 104.98 | 97.84 |
| Total Inventory | 228.67 | 190.66 | 141.32 | 160.18 |
| Prepaid Expenses | 10.96 | 11.77 | 10.82 | 8.39 |
| Other Current Assets Total | 2.11 | 0.20 | 0.04 | 0.01 |
| Total Current Assets | 932.71 | 835.47 | 705.67 | 618.76 |
| Property/ Plant/ Equipment Total- Gross | 185.16 | 180.45 | 171.03 | 163.80 |
| Accumulated Depreciation Total | -120.32 | -110.26 | -94.34 | -78.82 |
| Property/ Plant/ Equipment Total- Net | 64.84 | 70.19 | 76.69 | 84.98 |
| Intangibles Net | 2.11 | - | - | - |
| Note Receivable- Long Term | 54.65 | 55.44 | 54.97 | 56.43 |
| Other Long Term Assets Total | 23.72 | 20.67 | 16.30 | 14.54 |
| Total Assets | 1,078.03 | 984.87 | 856.56 | 774.71 |
| Accounts Payable | 196.51 | 227.88 | 188.06 | 178.37 |
| Accrued Expenses | 55.23 | 51.98 | 66.82 | 63.65 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Portof LT Debt/ Capital Leases | 1.81 | 3.52 | 3.61 | 3.51 |
| Other Currentliabilities Total | 103.57 | 100.55 | 74.16 | 57.97 |
| Total Current Liabilities | 357.12 | 383.93 | 332.65 | 303.50 |
| Capital Lease Obligations | 2.78 | 3.69 | 5.02 | 8.63 |
| Total Long Term Debt | 2.78 | 3.69 | 5.02 | 8.63 |
| Total Debt | 4.59 | 7.21 | 8.63 | 12.14 |
| Other Liabilities Total | 6.21 | 8.56 | 7.50 | 6.41 |
| Total Liabilities | 366.11 | 396.18 | 345.17 | 318.54 |
| Common Stock Total | 5.00 | 5.00 | 5.00 | 5.00 |
| Retained Earnings( Accumulated Deficit) | 703.63 | 581.12 | 504.44 | 449.58 |
| ESOP Debt Guarantee | 3.29 | 2.57 | 1.95 | 1.59 |
| Total Equity | 711.92 | 588.69 | 511.39 | 456.17 |
| Total Liabilities Shareholders' Equity | 1,078.03 | 984.87 | 856.56 | 774.71 |
| Total Common Shares Outstanding | 2.50 | 2.50 | 2.50 | 2.50 |
| Tangible Book Valueper Share Common Eq | 283.92 | 235.48 | 204.56 | 182.47 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Long Term Investments | - | 3.10 | 2.93 | - |
| Short Term Investments | - | - | 0.09 | 0.00 |
*All figures in crores except per share values
Astrazeneca Pharma India Quick Links
Astrazeneca Pharma India Dividend Astrazeneca Pharma India Bonus Astrazeneca Pharma India News Astrazeneca Pharma India AGM Astrazeneca Pharma India Rights Astrazeneca Pharma India Splits Astrazeneca Pharma India Board Meetings Astrazeneca Pharma India Key Metrics Astrazeneca Pharma India Shareholdings Astrazeneca Pharma India Profit Loss Astrazeneca Pharma India Cashflow Astrazeneca Pharma India Q1 Results Astrazeneca Pharma India Q2 Results Astrazeneca Pharma India Q3 Results Astrazeneca Pharma India Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
155.30+5.80(3.88%)
1,604.25+31.75(2.02%)
3,101.65+47.75(1.56%)
2,283.65-41.45 (-1.78%)
699.00-8.90 (-1.26%)